190
Views
5
CrossRef citations to date
0
Altmetric
Gestational Diabetes

Insulin-like growth factor binding protein-1 (IGFBP-1) during normal pregnancy

, , &
Pages 129-132 | Received 14 May 2012, Accepted 17 Jul 2012, Published online: 28 Nov 2012

References

  • Pekonen F, Suikkari AM, Mäkinen T, Rutanen EM. Different insulin-like growth factor binding species in human placenta and decidua. J Clin Endocrinol Metab 1988;67:1250–1257.
  • Julkunen M, Koistinen R, Aalto-Setälä K, Seppälä M, Jänne OA, Kontula K. Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett 1988;236:295–302.
  • Domené HM, Hwa V, Argente J, Wit JM, Wit JM, Camacho-Hübner C, Jasper HG, et al.; International ALS Collaborative Group. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Horm Res 2009;72:129–141.
  • Clemmons DR. IGF binding proteins and their functions. Mol Reprod Dev 1993;35:368–74; discussion 374.
  • Fowler DJ, Nicolaides KH, Miell JP. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update 2000;6:495–504.
  • Froment P, Seurin D, Hembert S, Levine JE, Pisselet C, Monniaux D, Binoux M, Monget P. Reproductive abnormalities in human IGF binding protein-1 transgenic female mice. Endocrinology 2002;143:1801–1808.
  • Cataldo NA, Giudice LC. Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 1992;74:821–829.
  • Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999;14 Suppl 2:90–96.
  • Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. J Clin Endocrinol Metab 2001;86:2060–2064.
  • Elson J, Tailor A, Salim R, Hillaby K, Dew T, Jurkovic D. Expectant management of miscarriage–prediction of outcome using ultrasound and novel biochemical markers. Hum Reprod 2005;20:2330–2333.
  • Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669–674.
  • Rajkumar K, Barron D, Lewitt MS, Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995;136:4029–4034.
  • Doublier S, Duyckaerts C, Seurin D, Binoux M. Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm IGF Res 2000;10:267–274.
  • Howell RJ, Economides D, Teisner B, Farkas AG, Chard T. Placental proteins 12 and 14 in pre-eclampsia. Acta Obstet Gynecol Scand 1989;68:237–240.
  • Tzschoppe AA, Struwe E, Dörr HG, Goecke TW, Beckmann MW, Schild RL, Dötsch J. Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta 2010;31:178–185.
  • Okamoto A, Endo H, Kalionis B, Shinya M, Saito M, Nikaido T, Tanaka T. IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. Placenta 2006;27:317–321.
  • Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 2006;155:567–574.
  • Davidson S, Hod M, Merlob P, Shtaif B. Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy. Clin Endocrinol (Oxf) 2006;65:586–592.
  • Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O, Spandidos DA. Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res 2011;21:31–36.
  • Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia. Prenat Diagn 2011;31:196–201.
  • Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks’ gestation in pregnancies delivering small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol 2012;161:30–33.
  • Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42:710–714.
  • Solberg HE. RefVal: a program implementing the recommendations of the International Federation of Clinical Chemistry on the statistical treatment of reference values. Comput Methods Programs Biomed 1995;48:247–256.
  • Olausson H, Lof M, Brismar K, Lewitt M, Forsum E, Sohlstrom A. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res 2008;69:99–106.
  • Clapp JF 3rd, Schmidt S, Paranjape A, Lopez B. Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. Am J Obstet Gynecol 2004;190:730–736.
  • Skjaerbaek C, Frystyk J, Orskov H, Flyvbjerg A. Free IGF-I, IGFBP-1, and the binary complex of IGFBP-1 and IGF-I are increased during human pregnancy. Horm Res 2004;62:215–220.
  • Åsvold BO, Eskild A, Jenum PA, Vatten LJ. Maternal concentrations of insulin-like growth factor I and insulin-like growth factor binding protein 1 during pregnancy and birth weight of offspring. Am J Epidemiol 2011;174:129–135.
  • Akram SK, Carlsson-Skwirut C, Bhutta ZA, Söder O. Placental IGF-I, IGFBP-1, zinc, and iron, and maternal and infant anthropometry at birth. Acta Paediatr 2011;100:1504–1509.
  • Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997;176:751–7; discussion 757.
  • Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548–1555.
  • Cooper S, Lange I, Wood S, Tang S, Miller L, Ross S. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol 2012;32:460–465.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.